Comparison of Efficacy and Safety of Rosuvastatin Versus Atorvastatin, Simvastatin and Pravastatin Across Doses
STELLAR Trial
18 Aug, 10
STELLAR Trial
Objective
To compare rosuvastatin with atorvastatin, simvastatin and pravastatin across dose ranges for reduction of lipid modifications.
Patient Population
N=2431; Patients with hypercholesterolemia (LDL ≥160 mg/dL and <250 mg/dL)
Study Treatment
Patients were randomized to receive 1 of the 15 treatment options once-daily: Rosuvastatin 10, 20, 40 or 80 mg; Atorvastatin 10, 20, 40 or 80 mg; Simvastatin 10, 20, 40 or 80 mg and Pravastatin 10, 20 or 40 mg.
Study Duration
6 weeks
Results
- Rosuvastatin gives greatest reduction in LDL at all doses as compared to other statins.
- Rosuvastatin gives greater and consistent increase in HDL as compared to other statins.
Conclusion
Rosuvastatin was superior in reducing LDL, total cholesterol, improving HDL and was similar or greater in reducing triglycerides.
Am J Cardiol 2003; 19: 689-98








